Last $0.22 USD
Change Today +0.014 / 6.97%
Volume 181.8K
DRIO On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 8:10 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

labstyle innovations corp (DRIO) Snapshot

Open
$0.20
Previous Close
$0.20
Day High
$0.22
Day Low
$0.20
52 Week High
01/29/14 - $12.45
52 Week Low
11/14/14 - $0.10
Market Cap
3.5M
Average Volume 10 Days
82.6K
EPS TTM
$4.87
Shares Outstanding
16.2M
EX-Date
--
P/E TM
0.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for LABSTYLE INNOVATIONS CORP (DRIO)

labstyle innovations corp (DRIO) Related Bloomberg News

View More Bloomberg News

labstyle innovations corp (DRIO) Related Businessweek News

No Related Businessweek News Found

labstyle innovations corp (DRIO) Details

LabStyle Innovations Corp., a mobile health company, develops and commercializes a patent-pending technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. Its primary product is Dario, which is a mobile, cloud-based, diabetes management solution, which includes novel software applications combined with a pocket-sized, blood glucose monitoring device. The company’s product consists of a lancet (to obtain a blood sample), a device-specific disposable test strip cartridge, and a smartphone-driven glucose reader adaptor, coupled with a smartphone app and cloud-based data services. LabStyle Innovations Corp. is pursuing patent applications in various jurisdictions covering the specific processes related to blood glucose level measurement, as well as various general methods of rapid blood, urine, and saliva tests using mobile devices and cloud-based services. The company was founded in 2011 and is headquartered in Ramat Gan, Israel.

18 Employees
Last Reported Date: 10/31/14
Founded in 2011

labstyle innovations corp (DRIO) Top Compensated Officers

Acting Chairman, Chief Executive Officer and ...
Total Annual Compensation: $127.4K
Advisor
Total Annual Compensation: $11.0K
Compensation as of Fiscal Year 2013.

labstyle innovations corp (DRIO) Key Developments

Labstyle Innovations Corp. Signs Partnership Agreement with HMO

LabStyle Innovations Corp. reported that it has signed a partnership agreement with HMO; Maccabi Healthcare to implement its comprehensive Dario digital suite for patients and professionals remote proactive care. The agreement with MOMA represents an additional channel of revenue stream for Dario. This channel for revenues indicates the huge potential available in the Dario digital health solution which is based on software licensing and added value services with HMOs and other strategic partners worldwide. The Dario application for MOMA is a proprietary customized diabetes management solution that enables remote treatment for diabetes aiming to improve the overall outcomes for patients leveraging mHealth technology for effective engagement of health care professionals. Through the agreement Maccabi Healthcare will be subscribing to Dario; a cutting edge diabetes management solution that includes an online diabetes solution together with the Dario smart meters for an advanced service they call MOMA. Through MOMA, Maccabi will provide chronic patients a service of advanced multi-disciplinary support and care through a national call center in coordination with the client's primary physician and other community-based resources. Each MOMA member with diabetes will receive their own Dario smart meter for managing and monitoring their diabetes in order to enable the caretakers at the call centers a direct online view and proactive communication over the Dario mobile platform.

LabStyle Innovations Corp. Announces Executive Changes

LabStyle Innovations Corp. announced that Zvi Ben-David will be joining as the company's new chief financial officer, treasurer and secretary effective immediately. LabStyle also announced that Gadi Levin, the current chief financial officer will remain in the role of advisor and business development consultant for at least the first half of 2015 as Mr. Ben-David transitions to his new role. Among his previous roles, he served as corporate vice president and chief financial officer of Given Imaging Ltd. Following his tenure at Given, Mr. Ben-David served as chief financial officer of Ultrashape Medical Ltd. Recently, Ben-David has been an independent medical device entrepreneur and investor.

LabStyle Innovations Corp. Appoints Peter Kash and Hila Karah to the Board of Directors

LabStyle Innovations Corp. announced that Dr. Peter Kash and Ms. Hila Karah have been appointed to serve on the company's Board of Directors. Dr. Kash and Ms. Karah bring significant experience in commercialization, finance and corporate governance of life science companies to LabStyle's board. Ms. Karah is expected to serve on the Compensation and Nominating Committees of the board. Dr. Kash and Ms. Karah are the designated appointees of Dicilyon Consulting and Investment Ltd. Dr. Kash currently serves as Executive Chairman of iOS app developer Time Flash LLC. Ms. Karah is an independent business consultant and an investor in several high-tech, biotech and Internet companies.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DRIO:US $0.22 USD +0.014

DRIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for DRIO.
View Industry Companies
 

Industry Analysis

DRIO

Industry Average

Valuation DRIO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABSTYLE INNOVATIONS CORP, please visit www.mydario.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.